Champions Oncology, Inc. (CSBR)
7.21
+0.04
(+0.52%)
USD |
NASDAQ |
Jan 16, 16:00
7.14
-0.07
(-0.97%)
Pre-Market: 20:00
Champions Oncology EPS Diluted (Quarterly): 0.0185 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.237M |
| Revenue (Quarterly) | 15.04M |
| Total Expenses (Quarterly) | 14.77M |
| Enterprise Value | 97.08M |
| Gross Profit Margin (Quarterly) | 49.32% |
| Profit Margin (Quarterly) | 1.58% |
| Earnings Yield | 2.31% |
| Operating Earnings Yield | 2.42% |
| Normalized Earnings Yield | 2.308 |